Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathological role of lipid interaction with α-synuclein in Parkinson's disease
Mari Suzuki, Kazunori Sango, Keiji Wada, et al.
Neurochemistry International (2018) Vol. 119, pp. 97-106
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Role of cholesterol and sphingolipids in brain development and neurological diseases
Ghulam Hussain, Jing Wang, Azhar Rasul, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 291
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 201
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Mylene Huebecker, Elizabeth B. Moloney, Aarnoud C. van der Spoel, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 134
Prion-Like Mechanisms in Parkinson’s Disease
Jiangnan Ma, Jing Gao, Jing Wang, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 117
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
Fabio Blandini, Roberto Cilia, Silvia Cerri, et al.
Movement Disorders (2018) Vol. 34, Iss. 1, pp. 9-21
Closed Access | Times Cited: 91
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Ruhul Amin, Cristina Quispe, Anca Oana Docea, et al.
Neurochemistry International (2022) Vol. 158, pp. 105376-105376
Closed Access | Times Cited: 39
Neurodegenerative Diseases: Their Onset, Epidemiology, Causes and Treatment
Sumera Zaib, Hira Javed, Imtiaz Khan, et al.
ChemistrySelect (2023) Vol. 8, Iss. 20
Closed Access | Times Cited: 24
Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room
Bryan A. Killinger, Ronald Melki, Patrik Brundin, et al.
npj Parkinson s Disease (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
Ling Hu, Mei-Xue Dong, Yanling Huang, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 61
Immunotherapy in Parkinson’s disease: Current status and future directions
Diptaman Chatterjee, Jeffrey H. Kordower
Neurobiology of Disease (2019) Vol. 132, pp. 104587-104587
Open Access | Times Cited: 56
A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice
Silke Nuber, Alice Y. Nam, Molly M. Rajsombath, et al.
Annals of Neurology (2020) Vol. 89, Iss. 1, pp. 74-90
Open Access | Times Cited: 56
Friend or Foe: Lipid Droplets as Organelles for Protein and Lipid Storage in Cellular Stress Response, Aging and Disease
Florian Geltinger, Lukas Schartel, Markus Wiederstein, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5053-5053
Open Access | Times Cited: 55
Brain lipidomics as a rising field in neurodegenerative contexts: Perspectives with Machine Learning approaches
Daniel Báez Castellanos, Cynthia Martín-Jiménez, Felipe Rojas-Rodríguez, et al.
Frontiers in Neuroendocrinology (2021) Vol. 61, pp. 100899-100899
Closed Access | Times Cited: 54
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
Sheng Li, Yanbing Liu, Sen Lu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Alpha-Synuclein and Lipids: The Elephant in the Room?
Alessia Sarchione, Antoine Marchand, Jean‐Marc Taymans, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2452-2452
Open Access | Times Cited: 40
Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids
Jing Zhao, Wenyan Lü, Yingxue Ren, et al.
Acta Neuropathologica (2021) Vol. 142, Iss. 5, pp. 807-825
Open Access | Times Cited: 38
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
Matthew Surface, Manisha Balwani, Cheryl Waters, et al.
Movement Disorders (2021) Vol. 37, Iss. 2, pp. 416-421
Open Access | Times Cited: 34
The association of lipids with amyloid fibrils
John M. Sanderson
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102108-102108
Open Access | Times Cited: 27
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism
Chi‐Jing Choong, César Aguirre, Keita Kakuda, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 5, pp. 573-595
Open Access | Times Cited: 13
Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson’s disease model via a β-arrestin2-biased mechanism
Jialei Zhu, Ting Sun, Jing Zhang, et al.
Brain Behavior and Immunity (2020) Vol. 90, pp. 259-271
Closed Access | Times Cited: 37
Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
Deqiang Han, Wei Zheng, Xueyao Wang, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 35
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Katharina Klatt‐Schreiner, Lucie Valek, Jun‐Suk Kang, et al.
Movement Disorders (2020) Vol. 35, Iss. 10, pp. 1822-1833
Open Access | Times Cited: 35
Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson’s disease related anxiety disorder
Mei-Xue Dong, Ling Hu, Youdong Wei, et al.
Neuroscience Letters (2021) Vol. 745, pp. 135626-135626
Closed Access | Times Cited: 32
Constitutive Endolysosomal Perforation in Neurons allows Induction of alpha-Synuclein Aggregation by Internalized Pre-Formed Fibrils
Anwesha Sanyal, Gustavo Scanavachi, Elliott Somerville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top